194 related articles for article (PubMed ID: 31061916)
1. Elamipretide Improves Mitochondrial Function in the Failing Human Heart.
Chatfield KC; Sparagna GC; Chau S; Phillips EK; Ambardekar AV; Aftab M; Mitchell MB; Sucharov CC; Miyamoto SD; Stauffer BL
JACC Basic Transl Sci; 2019 Apr; 4(2):147-157. PubMed ID: 31061916
[TBL] [Abstract][Full Text] [Related]
2. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
Sabbah HN; Gupta RC; Kohli S; Wang M; Hachem S; Zhang K
Circ Heart Fail; 2016 Feb; 9(2):e002206. PubMed ID: 26839394
[TBL] [Abstract][Full Text] [Related]
3. Reduced Myocardial Mitochondrial ROS Production in Mechanically Unloaded Hearts.
Scheiber D; Zweck E; Jelenik T; Horn P; Albermann S; Masyuk M; Boeken U; Saeed D; Kelm M; Roden M; Szendroedi J; Westenfeld R
J Cardiovasc Transl Res; 2019 Apr; 12(2):107-115. PubMed ID: 29589269
[TBL] [Abstract][Full Text] [Related]
4. Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide.
Daubert MA; Yow E; Dunn G; Marchev S; Barnhart H; Douglas PS; O'Connor C; Goldstein S; Udelson JE; Sabbah HN
Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29217757
[TBL] [Abstract][Full Text] [Related]
5. Linoleic acid improves assembly of the CII subunit and CIII2/CIV complex of the mitochondrial oxidative phosphorylation system in heart failure.
Maekawa S; Takada S; Nambu H; Furihata T; Kakutani N; Setoyama D; Ueyanagi Y; Kang D; Sabe H; Kinugawa S
Cell Commun Signal; 2019 Oct; 17(1):128. PubMed ID: 31619261
[TBL] [Abstract][Full Text] [Related]
6. Targeting mitochondrial dysfunction with elamipretide.
Obi C; Smith AT; Hughes GJ; Adeboye AA
Heart Fail Rev; 2022 Sep; 27(5):1925-1932. PubMed ID: 35037146
[TBL] [Abstract][Full Text] [Related]
7. High resolution respirometry analysis of polyethylenimine-mediated mitochondrial energy crisis and cellular stress: Mitochondrial proton leak and inhibition of the electron transport system.
Hall A; Larsen AK; Parhamifar L; Meyle KD; Wu LP; Moghimi SM
Biochim Biophys Acta; 2013 Oct; 1827(10):1213-25. PubMed ID: 23850549
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial structure and function are not different between nonfailing donor and end-stage failing human hearts.
Holzem KM; Vinnakota KC; Ravikumar VK; Madden EJ; Ewald GA; Dikranian K; Beard DA; Efimov IR
FASEB J; 2016 Aug; 30(8):2698-707. PubMed ID: 27075244
[TBL] [Abstract][Full Text] [Related]
9. Effects of
Sosa-Gutiérrez JA; Valdéz-Solana MA; Forbes-Hernández TY; Avitia-Domínguez CI; Garcia-Vargas GG; Salas-Pacheco JM; Flores-Herrera O; Téllez-Valencia A; Battino M; Sierra-Campos E
Biology (Basel); 2018 Jun; 7(3):. PubMed ID: 29949946
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive diagnostics of mitochondrial disorders in isolated lymphocytes with high resolution respirometry.
Pecina P; Houšťková H; Mráček T; Pecinová A; Nůsková H; Tesařová M; Hansíková H; Janota J; Zeman J; Houštěk J
BBA Clin; 2014 Dec; 2():62-71. PubMed ID: 26675066
[TBL] [Abstract][Full Text] [Related]
11. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice.
Zhao W; Xu Z; Cao J; Fu Q; Wu Y; Zhang X; Long Y; Zhang X; Yang Y; Li Y; Mi W
J Neuroinflammation; 2019 Nov; 16(1):230. PubMed ID: 31747905
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Mitochondrial Respiratory Chain Supercomplexes Using Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE).
Jha P; Wang X; Auwerx J
Curr Protoc Mouse Biol; 2016 Mar; 6(1):1-14. PubMed ID: 26928661
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Mitochondria in Heart Failure: A Translational Perspective.
Sabbah HN
JACC Basic Transl Sci; 2020 Jan; 5(1):88-106. PubMed ID: 32043022
[TBL] [Abstract][Full Text] [Related]
14. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
[TBL] [Abstract][Full Text] [Related]
15. Biphasic response of skeletal muscle mitochondria to chronic cardiac pressure overload - role of respiratory chain complex activity.
Schrepper A; Schwarzer M; Schöpe M; Amorim PA; Doenst T
J Mol Cell Cardiol; 2012 Jan; 52(1):125-35. PubMed ID: 22100228
[TBL] [Abstract][Full Text] [Related]
16. [Mitochondrial Dysfunction and Oligomer Formation in Neurodegenerative Diseases].
Okado-Matsumoto A
Rinsho Byori; 2016 Oct; 64(10):1180-1186. PubMed ID: 30609477
[TBL] [Abstract][Full Text] [Related]
17. Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.
Saad A; Herrmann SMS; Eirin A; Ferguson CM; Glockner JF; Bjarnason H; McKusick MA; Misra S; Lerman LO; Textor SC
Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916603
[TBL] [Abstract][Full Text] [Related]
18. Molecular Changes in Children with Heart Failure Undergoing Left Ventricular Assist Device Therapy.
Medina E; Sucharov CC; Nelson P; Miyamoto SD; Stauffer BL
J Pediatr; 2017 Mar; 182():184-189.e1. PubMed ID: 27908653
[TBL] [Abstract][Full Text] [Related]
19. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
[TBL] [Abstract][Full Text] [Related]
20. Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.
Petcherski A; Trudeau KM; Wolf DM; Segawa M; Lee J; Taddeo EP; Deeney JT; Liesa M
J Mol Biol; 2018 Dec; 430(24):4823-4833. PubMed ID: 30389435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
